Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Federal judge rules that Bill Essayli unlawfully served as Acting U.S. Attorney, raising concerns about attempts to circumvent Senate confirmation.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Federal judge rules that Bill Essayli unlawfully served as Acting U.S. Attorney, raising concerns about attempts to circumvent Senate confirmation.